PRESS RELEASE Accomplished research scientist and business professional Brings important skills for both clinical and ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, whose profits from blockbuster weight-loss ...

The United States is the biggest trading partner for the European Union and Britain, whose economies could be at risk from ...

Evotec Ag (Adr) ( (EVO) ) has released its Q3 earnings. Here is a breakdown of the information Evotec Ag (Adr) presented to its investors.

Danish pharmaceutical giant Novo Nordisk sees a significant increase in profits and sales despite production constraints.

a Novo Nordisk executive said. Compounds typically are allowed when drugs are in shortage. 5️⃣ ‘Too much grief’: A retired ...

Evotec AG (EVO) has released an update. Evotec AG’s recent financial performance showed a slight revenue decline of 1% to €575.7 million, ...

The European stock markets closed lower in Wednesday trading as the FTSE in London was down 0.07%, Germany's DAX retreated 1.14%, France's CAC slid 0.51%, the Stoxx Europe 600 dropped 0.59% and the ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by ...

Novo Nordisk is the company that makes the Ozempic and Wegovy drugs, part of the wildly popular GLP-1 class of drugs that have proven effective in reducing weight and treating diabetes. Demand has ...